BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25428558)

  • 1. Lymphatic filariasis in Peninsular Malaysia: a cross-sectional survey of the knowledge, attitudes, and practices of residents.
    Al-Abd NM; Nor ZM; Ahmed A; Al-Adhroey AH; Mansor M; Kassim M
    Parasit Vectors; 2014 Nov; 7():545. PubMed ID: 25428558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014.
    Graves PM; Sheridan S; Fuimaono S; Lau CL
    Parasit Vectors; 2020 Mar; 13(1):125. PubMed ID: 32164780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic Filariasis in Southwestern Nigerian Rural Communities: A Cross-sectional Survey of the Knowledge, Awareness, and Predisposing Factors.
    Oluwabiyi B; Oyeyemi OT; Olorunlana A; Omiyeniyi N; Koleosho A
    Ann Glob Health; 2016; 82(5):806-812. PubMed ID: 28283133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic.
    Keys HM; Noland GS; De Rochars MB; Blount S; Gonzales M
    Infect Dis Poverty; 2019 May; 8(1):39. PubMed ID: 31130142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
    Adhikari RK; Sherchand JB; Mishra SR; Ranabhat K; Wagle RR
    J Community Health; 2015 Feb; 40(1):34-40. PubMed ID: 24996654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
    Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
    Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.
    Derua YA; Kisinza WN; Simonsen PE
    Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
    Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
    PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
    Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
    Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.
    Simonsen PE; Derua YA; Magesa SM; Pedersen EM; Stensgaard AS; Malecela MN; Kisinza WN
    Parasit Vectors; 2014 Nov; 7():507. PubMed ID: 25387483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining non-compliance to mass drug administration for lymphatic filariasis elimination in endemic districts of Nepal.
    Adhikari RK; Sherchand JB; Mishra SR; Ranabhat K; Devkota P; Mishra D; Ghimire YC; Gelal K; Mishra R; Paudel R; Wagle RR
    J Nepal Health Res Counc; 2014; 12(27):124-9. PubMed ID: 25726571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.
    Sime H; Gass KM; Mekasha S; Assefa A; Woyessa A; Shafi O; Meribo K; Kebede B; Ogoussan K; Pelletreau S; Bockarie MJ; Kebede A; Rebollo MP
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006325. PubMed ID: 29579038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for positive lymphatic filariasis antibody in Sabah, Malaysia: a cross-sectional study.
    Zakaria ND; Avoi R
    Trans R Soc Trop Med Hyg; 2022 Apr; 116(4):369-374. PubMed ID: 34453834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.